Rapid7, Inc. provides cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brand names. The company offers Rapid7 Insight Agent, a software-based agent that is used on assets across on-premises and cloud environments to centralize and monitor data on company's platform; Rapid7 Insight Network Sensor that analyzes raw end-to-end network traffic to increase visibility into user activity, pinpoint real threats, and investigations; Rapid7 Cloud Event Data Harvesting that offers visibility into changes made to cloud resources; and third-party integrations and ecosystem, as well as orchestration and automation solutions. It also offers various platforms, including Rapid7 managed threat complete consisting of managed detection response that delivers end-to-end threat detection and response; Rapid7 threat complete consisting of InsightIDR, a security information and event management, and extended detection and response solution; Incident Response Services to prepare and respond to potential breaches; Exposure Command, an exposure management to provide attack surface visibility; and Exposure Command Advanced to provide strong security for workloads leveraging real-time visibility, identity analysis, and automated remediation. In addition, the company provides Surface Command, a Cyber Asset Attack Service Management solution to detect and prioritize security issues from endpoint to cloud; Vector Command, a continuous red-teaming service that validates the external attack surface exposures and tests defenses; InsightCloudSec, a cloud risk and compliance management solution; InsightAppSec, a dynamic application security testing tool; and InsightVM, a vulnerability management solution that provides visibility across on-premise and remote endpoints for security. Further, it offers offloads day-to-day, advisory, and professional services. The company was incorporated in 2000 and is headquartered in Boston, Massachusetts.

Rapid7 Inc.

In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Royalty Pharma, with a price target of $62.00...

Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Rapid7 (RPD), Freshworks (FRSH) and Adyen (ADYYF)....

Analysts Have Conflicting Sentiments on These Technology Companies: Rapid7 (RPD), Freshworks (FRSH) and Adyen (OtherADYYF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Rapid7 (RPD) and Skyworks Solutions (SWKS). Rapid7...

Analysts Offer Insights on Technology Companies: Rapid7 (RPD) and Skyworks Solutions (SWKS)

Analysts have been eager to weigh in on the Technology sector with new ratings on Klaviyo, Inc. Class A (KVYO), Advanced Micro Devices (AMD) and Ra...

Analysts’ Opinions Are Mixed on These Technology Stocks: Klaviyo, Inc. Class A (KVYO), Advanced Micro Devices (AMD) and Rapid7 (RPD)

Rapid7 Inc. (($RPD)) has held its Q1 earnings call. Read on for the main highlights of the call. Rapid7’s latest earnings call painted a cautiously...

Rapid7 Earnings Call Balances AI Vision With Headwinds

Analysts have been eager to weigh in on the Technology sector with new ratings on Rapid7 (RPD), Bill.com Holdings (BILL) and Ribbon Communications ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RPD	$7.19	-1.10%	1.91M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RPD	$7.19	-1.1%	1.91M
3
4
5
6

RPD

RPD

Compare Stocks

Start Your Comparison

Get Rapid7 Inc. Data in Excel

Get Rapid7 Inc. Data in Excel